FDA approves Emergent BioSolutions’ drug Anthrasil
Emergent BioSolutions Inc. (NYSE:EBS) has formally announced that the U.S. Food & Drug Administration (FDA) have approved of their drug: Anthrasil. This triggers a $7 million payment to the company, accordi...